Ube2L6 Promotes M1 Macrophage Polarization in High-Fat Diet-Fed Obese Mice via ISGylation of STAT1 to Trigger STAT1 Activation.

INTRODUCTION: In obesity-related type 2 diabetes mellitus (T2DM), M1 macrophages aggravate chronic inflammation and insulin resistance. ISG15-conjugation enzyme E2L6 (Ube2L6) has been demonstrated as a promoter of obesity and insulin resistance. This study investigated the function and mechanism of Ube2L6 in M1 macrophage polarization in obesity. METHODS: Obesity was induced in Ube2L6AKO mice and age-matched Ube2L6flox/flox control mice by high-fat diet (HFD). Stromal vascular cells were isolated from the epididymal white adipose tissue of mice. Polarization induction was performed in mouse bone marrow-derived macrophages (BMDMs) by exposure to IFN-γ, lipopolysaccharide, or IL-4. F4/80 expression was assessed by immunohistochemistry staining. Expressions of M1/M2 macrophage markers and target molecules were determined by flow cytometry, RT-qPCR, and Western blotting, respectively. Protein interaction was validated by co-immunoprecipitation (Co-IP) assay. The release of TNF-α and IL-10 was detected by ELISA. RESULTS: The polarization of pro-inflammatory M1 macrophages together with an increase in macrophage infiltration was observed in HFD-fed mice, which could be restrained by Ube2L6 knockdown. Additionally, Ube2L6 deficiency triggered the repolarization of BMDMs from M1 to M2 phenotypes. Mechanistically, Ube2L6 promoted the expression and activation of signal transducer and activator of transcription 1 (STAT1) through interferon-stimulated gene 15 (ISG15)-mediated ISGlylation, resulting in M1 macrophage polarization. CONCLUSION: Ube2L6 exerts as an activator of STAT1 via post-translational modification of STAT1 by ISG15, thereby triggering M1 macrophage polarization in HFD-fed obese mice. Overall, targeting Ube2L6 may represent an effective therapeutic strategy for ameliorating obesity-related T2DM.

Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves' disease patients through the gut-thyroid axis.

Graves' disease (GD) is an autoimmune disorder that frequently results in hyperthyroidism and other symptoms. Here, we designed a 6-month study with patients divided into three treatment groups, namely, methimazole (MI, n = 8), MI + black bean (n = 9) and MI + probiotic Bifidobacterium longum (n = 9), to evaluate the curative effects of probiotics supplied with MI on thyroid function of patients with GD through clinical index determination and intestinal microbiota metagenomic sequencing. Unsurprisingly, MI intake significantly improved several thyroid indexes but not the most important thyrotropin receptor antibody (TRAb), which is an indicator of the GD recurrence rate. Furthermore, we observed a dramatic response of indigenous microbiota to MI intake, which was reflected in the ecological and evolutionary scale of the intestinal microbiota. In contrast, we did not observe any significant changes in the microbiome in the MI + black bean group. Similarly, the clinical thyroid indexes of patients with GD in the probiotic supplied with MI treatment group continued to improve. Dramatically, the concentration of TRAb recovered to the healthy level. Further mechanistic exploration implied that the consumed probiotic regulated the intestinal microbiota and metabolites. These metabolites impacted neurotransmitter and blood trace elements through the gut-brain axis and gut-thyroid axis, which finally improved the host's thyroid function.

Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers.

Graves' Disease is the most common organ-specific autoimmune disease and has been linked in small pilot studies to taxonomic markers within the gut microbiome. Important limitations of this work include small sample sizes and low-resolution taxonomic markers. Accordingly, we studied 162 gut microbiomes of mild and severe Graves' disease (GD) patients and healthy controls. Taxonomic and functional analyses based on metagenome-assembled genomes (MAGs) and MAG-annotated genes, together with predicted metabolic functions and metabolite profiles, revealed a well-defined network of MAGs, genes and clinical indexes separating healthy from GD subjects. A supervised classification model identified a combination of biomarkers including microbial species, MAGs, genes and SNPs, with predictive power superior to models from any single biomarker type (AUC = 0.98). Global, cross-disease multi-cohort analysis of gut microbiomes revealed high specificity of these GD biomarkers, notably discriminating against Parkinson's Disease, and suggesting that non-invasive stool-based diagnostics will be useful for these diseases.

Promotion of TiO2 Nanotube-Confined Pt Nanoparticles via Surface Modification with Fe2O3 for Ethylene Oxidation at Low Temperature.

A modified confined catalyst with Pt nanoparticles on the interior and Fe2O3 on the exterior surface of TiO2 nanotubes (Pt-in/Fe2O3-TNTs) was prepared and investigated for catalyzing the oxidation of ethylene. Compared with the Pt-in/TNTs without Fe2O3 modification, the Pt-in/Fe2O3-TNTs exhibited a significantly enhanced activity, and the complete conversion temperature of ethylene decreased from 170 to 95 °C. X-ray photoelectron spectroscopy analysis indicated that the Pt nanoparticles were stabilized at higher oxidation states in the Pt-in/Fe2O3-TNT catalyst. It was proposed that the modification of Fe2O3 on the outer surface can tune the electronic state of the encapsulated Pt particles and accelerate the electrons transferred from Pt to Fe species via TiO2 nanotubes, thus improving the catalytic oxidation performance of the confined catalyst.

N2O inhibition by toluene over Mn-Fe spinel SCR catalyst.

Co-removal of toluene in NH3-SCR unit over Mn based catalysts is desirable but still faces the big challenge of byproduct greenhouse gas N2O. In this work, the impacts of toluene on N2O formation mechanism was studied. The main N2O formation pathways in NH3-SCR over Mn-Fe spinel were NH3 oxidation and non-catalytic selective reduction (NSCR), in which NSCR dominated below 250 °C. The N2O from NSCR through both Eley-Rideal (E-R) and Langmuir-Hinshelwood (L-H) mechanisms was confirmed. And the E-R mechanism was dominant at 200 °C. Toluene was effectively co-removed with NOx with the advantage of N2O inhibition. Toluene suppressed N2O generation from both NH3 oxidation and NSCR. NH3 oxidation by gaseous O2 and catalyst surface oxygen was all limited by toluene, resulting in less adsorbed NH that was further proved by the larger energy barriers of NH3*→NH2* and NH2*→NH* on toluene pre-adsorbed catalyst surface. NO oxidation was also limited, suppressing the generation of adsorbed NO3-. Due to the inhibition of NH3 and NO activation to key intermediates NH and NO3-, respectively, the N2O generation from E-R route was slightly decreased in the presence of toluene, while that from L-H route was completely prohibited at 200 °C.

Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers.

Current metagenomic species-based colorectal cancer (CRC) microbial biomarkers may confuse diagnosis because the genetic content of different microbial strains, even those belonging to the same species, may differ from 5% to 30%. Here, a total of 7549 non-redundant single nucleotide variants (SNVs) were annotated in 25 species from 3 CRC cohorts (n = 249). Then, 22 microbial SNV markers that contributed to distinguishing subjects with CRC from healthy subjects were identified by the random forest algorithm to construct a novel CRC predictive model. Excitingly, the predictive model showed high accuracy both in the training (AUC = 75.35%) and validation cohorts (AUC = 73.08%-88.02%). We further explored the specificity of these SNV markers in a broader background by performing a meta-analysis across 4 metabolic disease cohorts. Among these SNV markers, 3 SNVs that were enriched in CRC patients and located in the genomes of Eubacterium rectale and Faecalibacterium prausnitzii were CRC specific (AUC = 72.51%-94.07%).

Induction of long-term glycemic control in a type 2 diabetic patient for 11 years by intensive lifestyle intervention.

Can diabetes be reversed? Yes! The weight loss due to intensive lifestyle intervention leads to the recovery of islet ß cell function, thus changing the natural course of type 2 diabetes.

Metagenomic Analyses Expand Bacterial and Functional Profiling Biomarkers for Colorectal Cancer in a Hainan Cohort, China.

This study was conducted for the metagenomic analysis of stool samples from CRC affected individuals to identify biomarkers for CRC in Hainan, the only tropical island province of China. The gut microbiota of CRC patients differed significantly from that of healthy and reference database cohorts based on Aitchison distance and Bray-Cutis distance but there was no significant difference in alpha diversity. Furthermore, at the species level, 68 species were significantly altered including 37 CRC-enriched, such as, Fusobacterium nucleatum, Parvimonas micra, Gemella morbillorum, Citrobacter portucalensis, Alloprevotella sp., Shigella sonnei, Coriobacteriaceae bacterium, etc. Sixty-seven different metabolic pathways were acquired, and pathways involved in the synthesis of many amino acids were significantly declined. Besides, 2 identified antibiotic resistance genes performed well (area under the receive-operation curve AUC = 0.833, 95% CI 58.51-100%) compared with virulence factor genes. The results of the present study provide region-specific bacterial and functional biomarkers of gut microbiota for CRC patients in Hainan. Microbiota is considered as a non-invasive biomarker for the detection of CRC. Gut microbiota of different geographic regions should be further studied to expand the understanding of markers, especially for the China cohort due to diverse nationalities and lifestyles.

The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome.

Graves' disease, a typical metabolism disorder, causes diffuse goiter accompanied by ocular abnormalities and ocular dysfunction. Although methimazole (MI) is a commonly used drug for the treatment of GD, the efficacy of methimazole is only limited to the control of clinical indicators, and the side effects of MI should be seriously considered. Here, we designed a 6-month clinical trial that divided the patients into two groups: a methimazole group (n=8) and a methimazole combined with potential prebiotic berberine group (n=10). The effects of both treatments on thyroid function and treatment outcomes in patients with GD were assessed by thyroid index measurements and gut microbiota metagenomic sequencing. The results showed that the addition of berberine restored the patients' TSH and FT3 indices to normal levels, whereas MI alone restored only FT3. In addition, TRAb was closer to the healthy threshold at the end of treatment with the drug combination. MI alone failed to modulate the gut microbiota of the patients. However, the combination of berberine with methimazole significantly altered the microbiota structure of the patients, increasing the abundance of the beneficial bacteria Lactococcus lactis while decreasing the abundance of the pathogenic bacteria Enterobacter hormaechei and Chryseobacterium indologenes. Furthermore, further mechanistic exploration showed that the addition of berberine resulted in a significant upregulation of the synthesis of enterobactin, which may have increased iron functioning and thus restored thyroid function. In conclusion, methimazole combined with berberine has better efficacy in patients with GD, suggesting the potential benefit of berberine combined with methimazole in modulating the composition of intestinal microbes in the treatment of GD, providing new strong evidence for the effectiveness of combining Chinese and Western drugs from the perspective of modulating the intestinal microbiota.

Correction: Mechanistic study on NO reduction by sludge reburning in a pilot scale cement precalciner with different CO2 concentrations.

[This corrects the article DOI: 10.1039/C9RA04065J.].

Data on species and concentration of the main gaseous products during sludge combustion to support the feasibility of using sludge as a flue gas denitration agent for the cement industry.

The dataset presented in this article is the supplementary data for the research article Fang et al., 2019 [1] and provided detailed data profile to support that sludge is an effective NOX reducing agent, as reductive gas components produce during sludge combustion. The instantaneous concentrations of the main gaseous products during sludge combustion were detected by using Fourier transform infrared spectroscopy (FTIR, DX-4000, Gasmet Technologies). The results showed the distribution and concentration level of gaseous products during sludge combustion and evidenced the feasibility of using sludge as a deNOX agent in cement industry.

Mechanistic study on NO reduction by sludge reburning in a pilot scale cement precalciner with different CO2 concentrations.

An experimental study on the effects of CO2 concentration on the release of reducing gases and the NO reduction efficiency by sludge reburning was carried out in a pilot scale cement precalciner. The results indicate that sludge reburning shows an ideal NO reduction activity. The best NO reduction efficiency of 54% is reached when the CO2 concentration is 25 vol%. Characteristic analysis of the sludge shows that the main types of reducing gases generated by sludge reburning are HCN, NH3, CO and CH4. Among them, CO2 concentration plays a crucial role in the release of HCN, CO and CH4. The mechanistic study indicates that NO reduction is dominated by homogeneous reduction during the sludge reburning process, in particular the reducing gases of CO and NH3 have significant influences on the NO reduction. Meanwhile, the effect of CO2 concentration on NO reduction is mainly due to the difference in CO release. The results of the present study not only provide insight into the mechanism of NO reduction by sludge reburning, but could also contribute to the development of NO X removal technology in the cement industry.

CdS nanorod arrays with TiO2 nano-coating for improved photostability and photocatalytic activity.

CdS nanorod arrays were grown on fluorine-doped tin oxide glass substrates via a hydrothermal process and subsequently coated with a TiO2 nanolayer via a vacuum dip-coating process to fabricate a one-dimensional array structured photocatalyst. The TiO2 nanolayer improved the photocatalytic efficiency of CdS nanorod arrays for the degradation of methylene blue due to the effective separation of the electron-hole pairs, and the photocorrosion of CdS nanorod arrays was successfully inhibited.

[Purification of complicated industrial organic waste gas by complex absorption].

Complicated industrial organic waste gas with the characteristics of low concentration,high wind volume containing inorganic dust and oil was employed the research object by complex absorption. Complex absorption mechanism, process flow, purification equipment and engineering application were studied. Three different surfactants were prepared for the composite absorbent to purify exhaust gas loaded with toluene and butyl acetate, respectively. Results show that the low surface tension of the composite absorbent can improve the removal efficiency of toluene and butyl acetate. With the advantages of the water film, swirl plate and fill absorption device, efficient absorption equipment was developed for the treatment of complicated industrial organic waste gas. It is with superiorities of simple structure, small size, anti-jam and high mass transfer. Based on absorption technology, waste gas treatment process integrated with heating stripping, burning and anaerobic and other processes, so that emissions of waste gas and absorption solution could meet the discharge standards. The technology has been put into practice, such as manufacturing and spraying enterprises.